Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial

被引:100
|
作者
van der Marck, Marjolein A. [1 ]
Bloem, Bastiaan R. [2 ]
Borm, George F. [3 ]
Overeem, Sebastiaan [2 ]
Munneke, Marten [1 ,4 ]
Guttman, Mark [5 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Evidence Based Practice, Dept Neurol, NL-6525 ED Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Evidence Based Practice, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands
[5] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada
关键词
Parkinson disease; randomized; controlled trial; quality of life; multidisciplinary care; patient care team; QUALITY-OF-LIFE; MEMORY CLINICS; REHABILITATION; THERAPY; PEOPLE; HEALTH; INTERVENTIONS; QUESTIONNAIRE; STIMULATION; PROGRESSION;
D O I
10.1002/mds.25194
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multidisciplinary care is considered an optimal model to manage Parkinson's disease (PD), but supporting evidence is limited. We performed a randomized, controlled trial (RCT) to establish whether a multidisciplinary/specialist team offers better outcomes, compared to stand-alone care from a general neurologist. Patients with PD were randomly allocated to an intervention group (care from a movement disorders specialist, PD nurses, and social worker) or a control group (care from general neurologists). Both interventions lasted 8 months. Clinicians and researchers were blinded for group allocation. The primary outcome was the change in quality of life (Parkinson's Disease Questionnaire; PDQ-39) from baseline to 8 months. Other outcomes were the UPDRS, depression (Montgomery-Asberg Depression Scale; MADRS), psychosocial functioning (Scales for Outcomes in Parkinson's disease-Psychosocial; SCOPA-PS), and caregiver strain (Caregiver Strain Index; CSI). Group differences were analyzed using analysis of covariance adjusted for baseline values and presence of response fluctuations. A total of 122 patients were randomized and 100 completed the study (intervention, n = 51; control, n = 49). Compared to controls, the intervention group improved significantly on PDQ-39 (difference, 3.4; 95% confidence interval [CI]: 0.56.2) and UPDRS motor scores (4.1; 95% CI: 0.87.3). UPDRS total score (5.6; 95% CI: 0.910.3), MADRS (3.7; 95% CI: 1.45.9), and SCOPA-PS (2.1; 95% CI: 0.53.7) also improved significantly. This RCT gives credence to a multidisciplinary/specialist team approach. We interpret these positive findings cautiously because of the limitations in study design. Further research is required to assess teams involving additional disciplines and to evaluate cost-effectiveness of integrated approaches. (c) 2012 Movement Disorder Society
引用
下载
收藏
页码:605 / 611
页数:7
相关论文
共 50 条
  • [1] In-patient multidisciplinary rehabilitation for Parkinson's disease: A randomized controlled trial
    Monticone, Marco
    Ambrosini, Emilia
    Laurini, Alessandro
    Rocca, Barbara
    Foti, Calogero
    MOVEMENT DISORDERS, 2015, 30 (08) : 1050 - 1058
  • [2] Effectiveness of speech therapy in patients with Parkinson's disease - a randomized controlled trial
    Maas, J.
    de Vries, N.
    Bloem, B.
    Kalf, H.
    MOVEMENT DISORDERS, 2023, 38 : S824 - S825
  • [3] Rationale and Design of the IMPACT Study: A Cluster Controlled Trial to Evaluate Cost-Effectiveness of Multidisciplinary Care in Parkinson's Disease
    Van der Marck, M. A.
    Bloem, B. R.
    Mulleners, W.
    Hoogerwaard, E.
    Overeem, S.
    Adang, E.
    Borm, G.
    Munneke, M.
    MOVEMENT DISORDERS, 2010, 25 : S678 - S679
  • [4] Rationale and design of the IMPACT study: A cluster controlled trial to evaluate cost-effectiveness of multidisciplinary care in Parkinson's disease
    van der Marck, M. A.
    Bloem, B. R.
    Mulleners, W. M.
    Hoogerwaard, E. M.
    Overeem, S.
    Adang, E. M. M.
    Borm, G. F.
    Munneke, M.
    MOVEMENT DISORDERS, 2010, 25 (07) : S290 - S291
  • [5] Effectiveness of occupational therapy in Parkinson’s disease: study protocol for a randomized controlled trial
    Ingrid HWM Sturkenboom
    Maud J Graff
    George F Borm
    Eddy MM Adang
    Maria WG Nijhuis-van der Sanden
    Bastiaan R Bloem
    Marten Munneke
    Trials, 14
  • [6] Effectiveness of occupational therapy in Parkinson's disease: study protocol for a randomized controlled trial
    Sturkenboom, Ingrid H. W. M.
    Graff, Maud J.
    Borm, George F.
    Adang, Eddy M. M.
    Nijhuis-van der Sanden, Maria W. G.
    Bloem, Bastiaan R.
    Munneke, Marten
    TRIALS, 2013, 14
  • [7] Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT)
    van der Marck, Marjolein A.
    Munneke, Marten
    Mulleners, Wim
    Hoogerwaard, Edo M.
    Borm, George F.
    Overeem, Sebastiaan
    Bloem, Bastiaan R.
    LANCET NEUROLOGY, 2013, 12 (10): : 947 - 956
  • [8] Photobiomodulation in Parkinson's disease: A randomized controlled trial
    Santos, Luis
    del Olmo-Aguado, Susana
    Valenzuela, Pedro L.
    Winge, Kristian
    Iglesias-Soler, Eliseo
    Arguelles-Luis, Juan
    Alvarez-Valle, Samuel
    Parcero-Iglesias, Guillermo J.
    Fernandez-Martinez, Ana
    Lucia, Alejandro
    BRAIN STIMULATION, 2019, 12 (03) : 810 - 812
  • [9] Inpatient Enhanced Multidisciplinary Care Effects on the Quality of Life for Parkinson Disease: A Quasi-Randomized Controlled Trial
    Marumoto, Kohei
    Yokoyama, Kazumasa
    Inoue, Tomomi
    Yamamoto, Hiroshi
    Kawami, Yuki
    Nakatani, Ayumi
    Fukazawa, Yoshihiro
    Hosoe, Yayoi
    Yamasaki, Aki
    Domen, Kazuhisa
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2019, 32 (04) : 186 - 194
  • [10] The safety and effectiveness of mirabegron in Parkinson's disease patients with overactive bladder: a randomized controlled trial
    Moussa, Mohamad
    Abou Chakra, Mohamad
    Dabboucy, Baraa
    Fares, Youssef
    Dellis, Athanasios
    Papatsoris, Athanasios
    SCANDINAVIAN JOURNAL OF UROLOGY, 2022, 56 (01) : 66 - 72